964MO Entinostat, nivolumab and ipilimumab in advanced HER2-negative breast cancer (ETCTN-9844)
Authors:
- E.T. Roussos TorresETE.T. Roussos Torres
- J. LeathermanJLJ. Leatherman
- C. RafieCRC. Rafie
- A. BrufskyABA. Brufsky
- P. LorussoPLP. Lorusso
- J.P. EderJEJ.P. Eder
- V. ChungVCV. Chung
- Y. YuanYYY. Yuan
- M. DownsMDM. Downs
- A. O’connorAOA. O’connor
- R. PiekarzRPR. Piekarz
- H. StreicherHSH. Streicher
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 32, S833